Adobe Systems Inc vs Canopy Growth Corp — how do they compare? Adobe Systems Inc trades at $260.77 (market cap $104.82B), while Canopy Growth Corp trades at $1 (market cap $421.10M). The key difference: Adobe Systems Inc is far larger — about 248.9× Canopy Growth Corp's market cap, and Adobe Systems Inc is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| ADBE | CGC | |
|---|---|---|
Market Cap | $104.82B | $421.10M |
Volume | 5,187,646 | — |
Sector | Technology | Health |
52-Week High | $367.46 | $1.92 |
52-Week Low | $193.41 | $0.86 |
Enterprise Value | $106.26B | $378.55M |
Signals from Pluang's Aura AI — not financial advice
Adobe (ADBE) trades at $272.96, up 2.92% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with 2025 revenue of $23.77B and net income of $7.13B, maintaining exceptional profitability margins. Recent earnings beats and accelerating revenue growth contrast with market concerns about AI competition and CEO transition.
Adobe presents a compelling value opportunity trading below analyst consensus targets despite strong operational performance. Key risks include AI disruption threats and ongoing leadership transition, while institutional accumulation and positive earnings momentum support potential upside. The stock's current valuation multiples appear attractive relative to growth prospects.
No Aura AI signal available yet.
Trailing returns across standard periods
Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.
Read more on ADBE →Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →